chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms were congestion, shortness of breath, dry cough and a bit of a headache. I did a rapid test at home on 05/13/2022 which came back positive. I called the doctor the same day and when the doctor returned my call, he said based on my history, he would write an rx for Paxlovid but he didn't think I needed it. Also, said that since the rapid test was positive, I didn't need to get the PCR done. They recommended that I treat the symptoms I was having as needed. I still have some of those symptoms now.
Frozen shoulder; COVID arm/adverse reaction; Red patch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PERIARTHRITIS (Frozen shoulder), VACCINATION SITE REACTION (COVID arm/adverse reaction) and ERYTHEMA (Red patch) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIARTHRITIS (Frozen shoulder), VACCINATION SITE REACTION (COVID arm/adverse reaction) and ERYTHEMA (Red patch). At the time of the report, PERIARTHRITIS (Frozen shoulder), VACCINATION SITE REACTION (COVID arm/adverse reaction) and ERYTHEMA (Red patch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.
Husband stated around midnight after dose in morning wife started to vomit  frequently. He took her to ER , eyes were even blood spots on whites of eyes from vomiting so much. Temperature of 101.8 degrees. Husband states inflamed kidney, pneumonia from vomiting so much.
Covid vaccine was adminsitered to patient. Patient was asked if he normally does well with vaccines prior to being administered the vaccine and stated yes, but that he is not particularly fond of needles. Approximately 5-10 minutes after receiving the vaccine the patient collapsed off of the chair onto the floor in the waiting area. The patient was able to break his fall and did not hurt his head. The patient was helped into a laying position and was shortly given a bottle water. Patient declined the need for an ambulence. Patient is not diabetic. After about 15 min the patient was able to walk around. The patient's sister-in-law came to take the patient to urgent care just to be safe about the patient's condition
injection site arm itchy; injection site arm hot to touch; Vaccination site swelling; lethargic; nausea; Vaccination site pain; lymph nodes on injection site arm feel swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site arm hot to touch), LETHARGY (lethargic), VACCINATION SITE PRURITUS (injection site arm itchy), NAUSEA (nausea) and VACCINATION SITE PAIN (Vaccination site pain) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced LETHARGY (lethargic), NAUSEA (nausea), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes on injection site arm feel swollen). On 21-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injection site arm hot to touch), VACCINATION SITE PRURITUS (injection site arm itchy) and VACCINATION SITE SWELLING (Vaccination site swelling). On 14-Apr-2021, LETHARGY (lethargic) and NAUSEA (nausea) had resolved. On 18-Apr-2021, VACCINATION SITE PAIN (Vaccination site pain) had resolved. At the time of the report, VACCINATION SITE WARMTH (injection site arm hot to touch), VACCINATION SITE PRURITUS (injection site arm itchy), VACCINATION SITE LYMPHADENOPATHY (lymph nodes on injection site arm feel swollen) and VACCINATION SITE SWELLING (Vaccination site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.
Patient here now with first Shingrix 8/28/20 - can I give second even though;; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 28th August 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked could he/she give 2nd dose even though 6 months interval passed. The follow up would not be possible as no contact details were available.
SEVERE COUGH, URTICARIAL RASH ABOUT 10 HRS POST VACCINE ADMINISTRATION, ? MILD ANAPHYLACTOID RXN.
my arm hurt very bad; Fever of 103.5 F; every piece of my body hurt; joints and muscle hurt; sick as a dog; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm hurt very bad), PYREXIA (Fever of 103.5 F), MYALGIA (every piece of my body hurt), ARTHRALGIA (joints and muscle hurt) and ILLNESS (sick as a dog) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (my arm hurt very bad), PYREXIA (Fever of 103.5 F), MYALGIA (every piece of my body hurt), ARTHRALGIA (joints and muscle hurt) and ILLNESS (sick as a dog). On 25-Feb-2021, PYREXIA (Fever of 103.5 F) had resolved. At the time of the report, PAIN IN EXTREMITY (my arm hurt very bad), MYALGIA (every piece of my body hurt), ARTHRALGIA (joints and muscle hurt) and ILLNESS (sick as a dog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Started the symptoms the next day 12/24: worn down, cough, weak, chill, difficulty breathing.  On Sunday got worse 12/27:  Staff used inhaler.  Went to work and was sent home by his boss. slightly better today, still using inhaler.
Information has been received from a registered nurse concerning a 5 year old male with a history of anaphylaxis from a vaccination with MMR II (WAES#0705USA02140) who on 08-May-2007 at 11:30 was vaccinated subcutaneously in the right shoulder with a 0.5ml dose of Varivax. Suspect therapy included Dtap. It was reported that a 11:30 AM, the patient was vaccinated and 5 to 10 minutes later the first hive appeared at the right shoulder and the child had generalized pain. At 11:40 AM the child had hives all over his body and experienced an anaphylactic reaction. There was no respiratory distress, client was injected with an EpiPen. Ambulance was called and child was transported to hospital. Nurse stated that the child was much better following the EpiPen injection, responded well. Additional information from the registered nurse indicated that the patient's head was hurting and the child was having respiratory problems after receiving the vaccinations. The events were considered life threatening. After receiving the Epipen at the office the child was stable when he left the office via ambulance. The child was admitted to the hospital overnight for observation from inpatient service. This event was considered to be serious due to being immediately life-threatening and hospitalization. Additional information has been requested.
low tiers; This case was reported by a pharmacist via call center representative and described the occurrence of therapeutic response decreased in a 22-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced therapeutic response decreased. On an unknown date, the outcome of the therapeutic response decreased was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 1-Sep-2022 Reporter's Comment: Pharmacist reported that a patient had low tiers.  The patient was administrated with Twinrix 22 years ago. No adverse event was reported. No patient's identifiers, no lot number and expiration date and no vaccination date were provided. The reporter did not consent to follow-up.  Additional Supportive Information: The patient received Twinrix and had low tiers, which led to therapeutic response decreased.
Received shot of Menomune on Wednesday at health dept. Client now breaking out in rash on body. Mostly from chest up, not really on her face and few on her legs. About size of mosquito bite. No itching. No fever and feels fine. Referred to family doctor.
No adverse event; on unspecified date an unspecified number of patients were administered improperly stored PEDVAXHIB, ROTATEQ, and VAQTA; This spontaneous report was received from a medical assistant referring to a 4-months-old male patient. The patient's medical history, concurrent condition and concomitant medication were unknown.  On 22-OCT-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) vial of lot# S005878, expiration date reported as 26-NOV-2020, but upon internal validation established as 25-NOV-2020 (strength, dose, dose number and route of administration were unknown) for prophylaxis (product storage error).   On an unknown date, the vaccine was stored at a temperature above 47 degrees Fahrenheit/9 degrees Celsius (9.3 Celsius (C)) for 23 minutes. Previous temperature excursion was at a temperature above 47 degrees Fahrenheit/9 degrees Celsius (10.7 C) for 33 minutes, 47 degrees Fahrenheit/9 degrees Celsius (8.7 C) for 36 minutes, 47 degrees Fahrenheit/9 degrees Celsius (8.9 C) for 15 minutes and 47 degrees Fahrenheit/9 degrees Celsius (9 C) for 12 minutes. Digital data logger was involved. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1910USA012749:
Tinnitus / Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 23Apr2021 at 12:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included tubes in ears when younger but never tinnitus (ear tube insertion). The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 23Apr2021, the patient experienced tinnitus and ringing in ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus and ringing in ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
AUTOIMMUNE DISEASE THAT FLARED UP; SJOGREN'S SYNDROME; SEVERE VOMITING; CHILLS; FEVER; SEVERE NAUSEA; This spontaneous report received from a patient concerned a  female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included autoimmune disease. The patient was not pregnant at time of report. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 43AZ114(9), expiry: UNKNOWN) dose was not reported, 1 total administered on 05-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  The patient reported that on an unspecified date she had an autoimmune disease that was flared up, chills, fever, muscle and joint pain, swelling of hand and face, pain in her wrists, knees, elbows, hands, neck, and shoulders. Severe nausea and vomiting, swollen nodes in her armpits and groin area and are very painful. Also had severe fatigue. Patient also reported that she diagnosed with Sjogren's syndrome by an ophthalmologist. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the autoimmune disease that flared up, chills, fever, severe nausea, severe vomiting and Sjogren's syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210509147- COVID-19 VACCINE AD26.COV2.S-autoimmune disease that flared up. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE  20210509147- COVID-19 VACCINE AD26.COV2.S- Sjogren's syndrome. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
I experienced extreme pain in my neck and left shoulder with stiffness. It was so bad that I could not turn my head. I went to see my doctor and was prescribed an exercise to performed but it does not resolve my symptoms. They will go away and then return periodically.
TDaP vaccine was ordered by provider, was given a DTaP instead. Made provider and patient aware of incident. Provider discussed  possible side effects with patient and advised to contact our office if any side effects/concerns.
Hive-like rash on torso only. Mottled, splotchy appearance. Very itchy.
Severe blister at site, then dark bruising, weakness, dizziness, pain at the shoulder, chest and neck.
Fatigue, weak, and slightly light headed that lasted overnight but finally subsided throughout the next day Very annoying, dull headache that lasted for about 9 hours and was treated with acetaminophen Chills that lasted for about 1:30 hours Fever not sure the temperature Nausea that was treated with Pepto-Bismol
ineffectiveness of all of the vaccines cause me to wonder if these are all you're working on; covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "ineffectiveness of all of the vaccines cause me to wonder if these are all you're working on"; SUSPECTED COVID-19 (medically significant), outcome "unknown", described as "covid-19". Clinical Information: The patient got the initial two doses of the COVID vaccine and 6 months later the booster as well. Patient reported the ineffectiveness of all of the vaccines.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Initial report was received from a health care professional on 18 October 2011. A 37-year-old female patient had received an Intradermal (ID) injection of FLUZONE; lot number UT4164BA in right deltoid on 17 October 2011. On 18 October 2011, the patient developed a "2.5" inch diameter red, swollen, painful, sore and burning at the right deltoid. She also experienced headache and nausea. No further informational was available at the time of the report. The patient outcome was reported as not recovered/not resolved. Documents held by sender: none.
Right leg edema and redness - treat with oral Benadryl and Tylenol or Motrin.
Chills, fever, achy joints, high heart rate, UTI symptoms.  UTI symptoms and achy joints happened same day as vaccine.  Achy joints a couple hours after vaccine.  UTI at 14:15, that hit me instantaneously.  Chills, fever and high heart rate hit me the next day. 12/31/2020. That's when I went and the sent me to the ER.
pt recv 1/2tsp APAP 930AM;went to day care 10-6PM;pt was lethargic w/temp below 101;appetite pretty good;APAP repeated 1:30 & 5:30;pt put to bed in heavy sleeper & blanket to sweat;pt awoke 1230AM fussy APAP given sz 12:40 x 1min t103;
Breaking out in hives when having contact with a substance previously tolerated with mild itchiness. Touching objects that the original substance touched cause hives for over 1 week and counting.
pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Ocular myasthenia.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain). At the time of the report, MYALGIA (pain) had not resolved.            No relevant concomitant medications were reported.  Treatment information was not provided.
Right back arm that is warm to touch, 4-5 inches in diameter with redness.  inner area of redness has a hard area that is about 2 inches in diameter.  Encourage to alternate cool and warm compresses to area. ENC patient to mark area with sharpie to monitor redness/swelling. F/U with PCP as needed.
On 09/02/2000, the patient developed a fever of greater than 102F and on 09/04/2000, developed a rash consistent with varicella on her trunk, limbs, and face. Unspecified medical attention was sought. On 09/11/2000, the patient recovered.
Received VARIVAX on 8-26-11 in (R) upper arm.
Within 2 hours patient experienced moderate headache, with visual disturbances specifically depth perception problems and weakness.  Left arm also extremely sore. Patients vitals taken and stable but placed in bed and allowed to rest and then sent home.
Pt received Pneumococcal 23 in AM of 5/7/01 and that evening, she developed shaking-chills, body aches, headache and discomfort at injection site. On 5/8/01, she was seen and evaluated by NP who ordered CXR for her cough and this was negative. She was started on Biaxin XL 500mg, 2 tabs together for 7 days. She was cautioned to return to office if symptoms exacerbate and redness increases over 1 cm, over the next 48 hours. She returned to office on 5/9/01 and was seen by physician who ordered labs, started her on Dicloxacillin and ordered injection of Rocephin. She was to monitor symptoms and report to ER if the symptoms got worse or higher temperatures. We telephoned her each day, to monitor her progress. Addendum: On 5/14/01, she returns to office with her daughter and her arm looks much better, only small area of hardness at injection site.
Received vaccine at approx 2:PM on 10-15-07, within 14 hours experienced excruciating, disabling, burning pain in legs and feet upon standing and  arms and hands when hanging at sides. Pain radiated down entire back of leg to bottom of foot and continued on to top of foot. Pain in arms and hands radiated down backs of arms and hands and produced numbness in wrists and hands. Walking, sitting and lying down produced minimal pain. Standing still produced pain of "10" on a scale of 1 to 10 resulting in loss of 3-1/2 days of work. Pain gradually subsided completely after 6 full days.
Pt lost consciousness fell to floor NH4 inhalent to revive, pressure applied to laceration on chin superficial cut to central area of lower chin; refused ambulance; pt taken by husband to pvt MD;
Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV disease. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) for an unknown indication.    On 31-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days). On 31-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was not known any treatment was given to the patient as the reporter did not know if the patient had experienced any symptoms after vaccination. Vials were moved to the fridge on 28 December 2021 for 30 day expiration on 27 January 2022.
Fussiness, decreased appetite, low grade fever, tachycardia to 150- 180s.
severe pain in Right shoulder blade + clavicle, pt can't lift arm to well. Stated pain kept her up 1st night has improved slight
Body aches, 2 days Temperature (101.2 was the high) 1.5 days Muscle pain (sharp and dull/aches) 2 days Fatigue ongoing  Headache  ongoing  Woozy feeling Tylenol
Nausea, Body aches, joint aches, tiredness, chills, light headed.  Feeling "off".  No treatment
pt recv vax & 9hr p/vax nausea & chills-12hr p/inj;felt sick all noc;malaise & h/a  all day 5OCT97;today feels better lt arm reddened above elbow 5-6" (backside of arm) warm to touch;no longer has chills;warm compresses;
Headache, Bleeding, Myalgia chills severe crampy abd pain vaginal bleeding Narrative: